Researchers from King’s College London have explored the role of beliefs about low and high glucose levels in ~2000 adults with type 1 diabetes
Tag: Diabetes Care
The ACBRD celebrates the graduation of Dr Virginia Hagger
We congratulate Dr Virginia Hagger, who was awarded her PhD in Psychology at a graduation ceremony at Deakin University’s Geelong Waterfront campus on Wednesday 13 February.
HypoCOMPaSS study demonstrates 20-fold reduction in severe hypoglycaemia is sustained over 2 years following brief psycho-educational intervention and 6 months intensive clinical support
Prof Jane Speight’s collaboration with UK researchers has been published in Diabetes Care
Does a focus on food increase risk of disordered eating behaviours in teens with type 1 diabetes?
A US study has found a family-based intervention was effective in improving healthy eating in youth with type 1 diabetes, without increasing their risk for disordered eating.
by Dr Christel Hendrieckx
5 reasons why being kind to yourself is good for your diabetes
On World Kindness Day 2017 we are highlighting why self-compassion matters when it comes to diabetes management.
by Dr Adriana Ventura
Clinically-meaningful cut-points for diabetes distress among adolescents with type 1 diabetes
A new publication from the ACBRD highlights the high proportion of adolescents with type 1 diabetes who experience clinically-significant diabetes distress.
by Virginia Hagger
Strengths and resilient outcomes in adolescents with type 1 diabetes
The Centre publishes a peer-reviewed journal article from the MILES Youth study in Diabetes Care.
by Virginia Hagger
New US web-based program identifies risk and offers support to drives with type 1 diabetes
An overview of a study published about predicting and reducing driving mishaps among drivers with type 1 diabetes.
by Dr Steven Trawley
A study of 1,503 adults with type 1 diabetes measured barriers to device uptake (insulin pump and continuous blood glucose monitors (CGM)) and compared the profiles of device users versus nonusers. For the whole sample, from a list of 19, the three most commonly endorsed barriers to diabetes device uptake were ‘cost of supplies’ (61%), ‘cost of device’ (57%) and ‘insurance coverage’ (57%), all of which were deemed to be ‘non-modifiable’ barriers by the authors. The top three commonly endorsed ‘modifiable’ barriers were ‘hassle of wearing devices all of the time’ (47%), ‘do not like having diabetes devices on my body’ (35%) and ‘do not like how diabetes devices look on my body’ (26%).
Read more










